Cargando…

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches

Detalles Bibliográficos
Autores principales:	Giannoukakis, Nick, McCommis, Kyle S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390066/ https://www.ncbi.nlm.nih.gov/pubmed/37529604 http://dx.doi.org/10.3389/fendo.2023.1253604

Ejemplares similares

Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
por: Niranjan, Sitara, et al.
Publicado: (2023)

The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease
por: McCommis, Kyle S., et al.
Publicado: (2023)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2017)

Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease
por: Furthner, Dieter, et al.
Publicado: (2022)

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
por: Che, Wensheng, et al.
Publicado: (2022)

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
por: Sasaki, Akira, et al.
Publicado: (2014)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
por: Kamm, Dakota R., et al.
Publicado: (2021)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple
por: Yuan, Liyun, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice
por: Garciafigueroa, Yesica, et al.
Publicado: (2021)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Cardiac‐specific Hexokinase 2 Overexpression Attenuates Hypertrophy by Increasing Pentose Phosphate Pathway Flux
por: McCommis, Kyle S., et al.
Publicado: (2013)

Editorial: Puberty: neurologic and physiologic development
por: Henriques-Neto, Duarte, et al.
Publicado: (2023)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Editorial: Adrenal Cortex: From Physiology to Disease
por: Val, Pierre, et al.
Publicado: (2016)

Editorial: Mitochondrial Dynamics in Endocrine Physiology and Disease
por: Poderoso, Cecilia, et al.
Publicado: (2022)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing
por: Huang, Xiaoyan, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
por: Memaj, Plator, et al.
Publicado: (2022)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

Editorial: Bone Marrow Adiposity: Establishing Harmonized, Mechanistic, and Multidisciplinary Approaches to Reach Clinical Translation
por: Lucas, Stephanie, et al.
Publicado: (2020)

Editorial: Mechanistic, machine learning and hybrid models of the “other” endocrine regulatory systems in health & disease
por: DiStefano, Joseph, et al.
Publicado: (2023)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population
por: Chen, Yi, et al.
Publicado: (2021)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish
por: Zou, Yun-Yi, et al.
Publicado: (2023)

Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology
Publicado: (2023)

Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
por: Liu, Linbo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2a67j5hqth8edj6kkkje2miq6o